Salesforce today announced that its board of directors declared a quarterly cash dividend of $0.40 per share. The dividend is payable October 8, 2024, to stockholders of record on September 18, 2024.

AbbVie Declares Quarterly Dividend

10:13am, Friday, 06'th Sep 2024
NORTH CHICAGO, Ill. , Sept. 6, 2024 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.55 per share.
Pharmaceutical (PPH) stocks have done relatively well this year. The closely watched iShares US Pharmaceutical ETF (IHE) stock has jumped by 16.5%, slightly beating the S&P 500 index, which has risen
Hims & Hers is rapidly picking up steam in the telehealth industry. UnitedHealth's dominance has created massive wealth for long-term investors.
Investors who own ABBV stock may stay invested as the company has faced its biggest challenge, Humira's patent cliff, quite well and looks set to return to robust growth next year.
AbbVie NYSE: ABBV is a global biopharmaceutical company long synonymous with its blockbuster drug, Humira. While the drug's success has propelled AbbVie to great heights, its recent patent expiration

What's Behind The 2x Jump In AbbVie Stock?

08:00am, Tuesday, 03'rd Sep 2024
AbbVie stock (NYSE: ABBV) has more than doubled in value since early January 2021 - jumping from levels of $90 then to around $195 now - vs. an increase of about 50% for the S&P 500 over this period.
These two companies sell products that remain in high demand even during recessions. They also have excellent dividend track records -- and one of them is a Dividend King.
Historically, September is a relatively bad month for stock markets. AT&T offers a huge dividend yield and it could start raising the payout again next year.
Consumers are still spending money on healthcare and fast-casual dining. AbbVie is a faithful dividend payer with a blockbuster portfolio.
Abbott Labs produces medications as just one of its revenue sources. AbbVie has shown a knack for expanding the markets of its drugs.
Both of these stocks have something to offer income-seeking investors. AbbVie is moving on from the loss of patent exclusivity for the world's top-selling drug.
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

AbbVie Already Has The Next Humira

10:00am, Thursday, 29'th Aug 2024
AbbVie delivered Y/Y growth in the second quarter despite Humira's decline, with Skyrizi and Rinvoq as key growth drivers, achieving 45% and 56% Y/Y growth, respectively. I expect Skyrizi to become a
AbbVie is a Dividend King that has proven it can successfully navigate challenges. Lowe's Companies is a great stock to own over the long run because homes will always need to be fixed up.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE